Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 5, 2004

View Archived Issues

Rosiglitazone inhibits keratinocyte proliferation

HMG-CoA reductase mediates the anticortisol effect of procaine

Novel CCK2B selective agonist with original pharmacological properties described

NHE exchanger inhibitor SM-20220 protective against excitotoxicity

Ampligen protects against coxsackie B3 virus-induced myocarditis

Acambis restructures and reprioritizes

Novel DPP-IV inhibitors under study at Sanofi-Synthelabo

U. of Tennessee researchers design new selective androgen receptor modulators

New 5-HT2C agonists for obesity and other disorders covered by Biovitrum patent

BMS team prepares and tests new anti-HIV agents

Aniline-based factor VIIa inhibitors newly identified at BMS

Two series of protein kinase modulators patented by Cellular Genomics

Takeda describes new prodrugs of proton pump inhibitors and their use

Sanofi-Synthelabo claims novel TNF-alpha production inhibitors for inflammation and pain

Bayer to distribute Testim in Canada

Shareholder approval of Genome Therapeutics/Genesoft merger

BioSante updates development progress

Registrational satraplatin trial expanded into Europe

Xcel acquires retigabine rights from Viatris

Caduet receives FDA approval

Roche and AEterna enter Brazilian marketing agreement for Impavido

Roll-out of Zyprexa

Positive preclinical results for GLP1-I.N.T

Treatment completed in phase II FM-VP4 trial

Development status of Arius antibodies

Bone Care International reports very productive Q2 FY2004

Altana sustains growth throughout 2003

Unacceptable safety profile found for HRT in breast cancer survivors

A phase II clinical trial shows no effects for repifermin in cancer therapy-induced mucositis

OrthoLogic continued progress with Chrysalin product platform during the past year

Merck & Co. highlights efforts to drive long-term growth in 2003

Cell Genesys reports developments of lead product candidate GVAX over past year

Kissei obtains marketing approval of Glufast in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...